Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease
Hospitals use blood levels to decide treatment, so the earlier the draw, the better the outcome
Retatrutide is a synthetic peptide studied in research settings for how it interacts with multiple receptor pathways at the same time
A control group of non-diabetes patients (1:3 ratio) was matched using a propensity score including age, sex, geography, health coverage, social deprivation index, and diabetes unrelated cancer presence (2017-2021)
[2] Mazdutides phase II trial in adults with obesity or excess weight showed approximately 10-14% weight loss at 4 mg and 6 mg doses over 32 to 48 weeks, with ongoing phase III trials investigating higher doses and effects on type 2 diabetes
Associ la vitamine C et l acide alpha-lipoque , son effet est renforc, mais les rsultats demandent du temps, gnralement entre 3 et 6 mois de prise rgulire